Clinical Trials on Rhinitis Medicamentosa in New Zealand

Total 181 results

Atlas Molecular Pharma

Completed

Study to Assess the Safety and Pharmacokinetics of ATL-001 (Ciclopirox Olamine) in Healthy Volunteers

Adverse Effect of Drugs and Medicaments in Therapeutic Use

United States
AstraZeneca

Completed

Safety and Effectiveness of Ciclesonide Nasal Spray in Patients With Perennial Allergic Rhinitis During One Year Treatment (BY9010/M1-404)

Allergic Rhinitis | Perennial Allergic Rhinitis | Hay Fever

United States
Sanofi

Completed

Single Center, Randomized, Double-Blind,Crossover Study Comparing Effects Of Single-Dose Fexofenadine HCl 180 mg, Cetirizine 10 mg, and Placebo on Cognitive Performance in Naval Flight Personnel

Seasonal Allergic Rhinitis

United States
Apotex Inc.

Completed

A Study Comparing the Bioequivalence of Triamcinolone Acetonide Aqueous Nasal Spray (Apotex, Inc.) to That of Nasacort® AQ Nasal Spray (Sanofi-Aventis Pharmaceutical Products, Inc.) In the Treatment of Seasonal Allergic Rhinitis

Seasonal Allergic Rhinitis

United States
Allergy Therapeutics

Completed

Dose Selection Study of Efficacy and Safety of Different Doses of Grass MATA MPL and Grass MATA Using mEECs™

Seasonal Allergic Rhinitis

United States
Sanofi

Completed

Single-Center, Double-Blind, Randomized , Parallel Study Comparing Onset of Action, Efficacy & Safety of a Single-Dose of Fexofenadine HCl 180 mg vs Montelukast Na 10 mg & Placebo in Treating Seasonal Allergic Rhinitis Subjects in an Allergen Exposure Unit

Seasonal Allergic Rhinitis

United States
Sunovion

Completed

Clinical Trial to Assess the Efficacy and Safety of Ciclesonide Hydrofluoroalkane (HFA) Nasal Aerosol for the Treatment of Seasonal Allergic Rhinitis (SAR) to Mountain Cedar in Subjects 12 Years and Older

Seasonal Allergic Rhinitis

United States
Idorsia Pharmaceuticals Ltd.

Completed

Study of ACT-129968 in Adult Patients With Seasonal Allergic Rhinitis (SAR)

Seasonal Allergic Rhinitis

United States
Meda Pharmaceuticals

Completed

A Study to Evaluate the Safety and Effectiveness of a Nasal Spray to Treat Seasonal Allergies

Seasonal Allergic Rhinitis

United States
Meda Pharmaceuticals

Completed

Study to Evaluate the Safety and Tolerability of a Nasal Spray in Patients With Chronic Allergic or Nonallergic Rhinitis

Chronic Allergic Rhinitis | Nonallergic Rhinitis

United States
Merck Sharp & Dohme LLC

Completed

A Study of Epinastine Nasal Spray in Subjects With Seasonal Allergic Rhinitis

Seasonal Allergic Rhinitis

United States
Allergy Therapeutics
SynteractHCR; Metronomia Clinical Research GMBH

Completed

A Study of Tolerability and Safety of a New Cumulative Dose of Grass MATA MPL (G104)

Seasonal Allergic Rhinitis

United States
Meda Pharmaceuticals

Completed

A Study to Evaluate the Safety and Effectiveness of a Nasal Spray to Treat Seasonal Allergies

Seasonal Allergic Rhinitis

United States
GlaxoSmithKline

Completed

Study In Adults And Adolescents With Seasonal Allergic Rhinitis

Rhinitis, Allergic, Seasonal | Seasonal Allergic Rhinitis | Hayfever

United States
Idorsia Pharmaceuticals Ltd.

Completed

Efficacy, Safety, and Tolerability Study of ACT-129968 in Patients With Seasonal Allergic Rhinitis (SAR)

Seasonal Allergic Rhinitis

United States
Sunovion

Completed

Clinical Trial to Assess the Efficacy and Safety of Ciclesonide Hydrofluoroalkane (HFA) Nasal Aerosol for the Treatment of Seasonal Allergic Rhinitis

Seasonal Allergic Rhinitis

United States
Meda Pharmaceuticals

Completed

A Study to Evaluate the Safety and Effectiveness of a Nasal Spray to Treat Seasonal Allergies

Seasonal Allergic Rhinitis

United States
Glenmark Pharmaceuticals Ltd. India

Completed

To Study GSP 301 in Patients With Seasonal Allergic Rhinitis

Seasonal Allergic Rhinitis

United States
Amneal Pharmaceuticals, LLC
Novum Pharmaceutical Research Services

Completed

Study to Compare the Therapeutic Equivalence of Mometasone Furoate Nasal Spray, 50 mcg With Nasonex Nasal Spray in the Relief of the Signs and Symptoms of Seasonal Allergic Rhinitis

Seasonal Allergic Rhinitis

United States
Sunovion

Completed

Study of the Effects of Ciclesonide Hydrofluoroalkane (HFA) Nasal Aerosol on Hypothalamic-Pituitary-Adrenal (HPA) Axis

Perennial Allergic Rhinitis

United States
GlaxoSmithKline

Completed

A Relative Bioavailability Study of Fluticasone Furoate and Levocabastine

Rhinitis, Allergic, Perennial and Seasonal

Australia
Actavis Inc.
Watson Laboratories, Inc.

Completed

Clinical Equivalence Study of Mometasone Nasal Spray

Seasonal Allergic Rhinitis

United States
Teva Branded Pharmaceutical Products R&D, Inc.

Completed

Study in Adult and Adolescent Subjects With Seasonal Allergic Rhinitis (SAR)

Seasonal Allergic Rhinitis | Hay Fever

United States
Glenmark Specialty S.A.

Completed

Long Term Safety and Efficacy of Fixed Dose Combination GSP 301 Nasal Spray (NS) in the Treatment of Perennial Allergic Rhinitis (PAR) (GSP 301-303)

Perennial Allergic Rhinitis

United States
Teva Branded Pharmaceutical Products R&D, Inc.
United BioSource, LLC

Completed

Effectiveness of Beclomethasone Dipropionate Nasal Aerosol for Perennial Allergic Rhinitis (BALANCE)

Perennial Allergic Rhinitis (PAR)

United States
Glenmark Specialty S.A.

Completed

Efficacy and Safety of GSP 301 Nasal Spray in the Treatment of Seasonal Allergic Rhinitis (SAR) (GSP 301-304)

Seasonal Allergic Rhinitis (SAR)

United States
Padagis LLC

Completed

Comparative Safety and Efficacy of Two Steroid Treatments in the Relief of the Symptoms of Seasonal Allergic Rhinitis

Seasonal Allergic Rhinitis

United States
Teva Branded Pharmaceutical Products R&D, Inc.

Completed

Hypothalamic-Pituitary-Adrenal (HPA) Axis Study in Adult and Adolescent Subjects With Perennial Allergic Rhinitis (PAR)

Perennial Allergic Rhinitis

United States
Meda Pharmaceuticals

Completed

A Study to Evaluate the Safety and Efficacy of Two Nasal Sprays to Treat Seasonal Allergies

Seasonal Allergic Rhinitis

United States
GlaxoSmithKline

Completed

Once-Daily Investigational Nasal Spray In Adults And Adolescents With Perennial Allergic Rhinitis (PAR)

Rhinitis, Allergic, Perennial

Australia, Estonia, United States, Germany, Canada, New Zealand, Russian Federation, Lithuania, Latvia
Glenmark Specialty S.A.

Completed

Efficacy and Safety of Fixed Dose Combination GSP 301 Nasal Spray (NS) in the Treatment of Seasonal Allergic Rhinitis (SAR) (GSP 301-301)

Seasonal Allergic Rhinitis

United States
Meda Pharmaceuticals

Completed

A Study to Evaluate the Safety and Efficacy of a Nasal Spray to Treat Seasonal Allergies

Seasonal Allergic Rhinitis

United States
Sunovion

Completed

Evaluation of a Novel Questionnaire to Assess Patient Satisfaction With and Preference of Intranasal Corticosteroids for the Treatment of Allergic Rhinitis

Perennial Allergic Rhinitis

United States
Johnson & Johnson Consumer and Personal Products...

Completed

To Determine if Diphenhydramine Works for Nasal Congestion at Two Different Doses

Nasal Congestion

United States
Magna Pharmaceuticals, Inc.

Completed

Trial of STAHIST in Seasonal Allergic Rhinitis

Seasonal Allergic Rhinitis

United States
Community and Patient Preference Research Pty Ltd
Seqirus; Glenmark Pharmaceuticals S.A.

Completed

Patient Satisfaction and Sensory Attributes Allergic Rhinitis Nasal Spray

Allergic Rhinitis

Australia
Bayer

Completed

A Study to Evaluate Cooling Sensation of an Allergy Product in Adults With a History of Allergies

Allergic Rhinitis

United States
Sanofi

Completed

Fexofenadine HCl 180 mg, Desloratadine 5 mg and Placebo in Suppression of Wheal and Flare Induced by Histamine

Allergic Rhinitis

United States
Sanofi

Completed

Fexofenadine HCl 180 mg, Montelukast Sodium 10 mg and Placebo in Suppression of Wheal and Flare Induced by Seasonal Allergen

Allergic Rhinitis

United States
Sanofi

Completed

Fexofenadine (Allegra®) in Healthy Adults Who Have Been Identified as Slow Metabolizers for Desloratadine

Allergic Rhinitis

United States
Meda Pharmaceuticals

Completed

Safety and Efficacy Trial of Dymista Nasal Spray in Children Ages 4 to 11 With Seasonal Allergic Rhinitis (SAR)

Seasonal Allergic Rhinitis

United States
Sanofi

Completed

An Efficacy and Safety Evaluation of Nasacort AQ in Children Ages 2-5 Years With Perennial Allergic Rhinitis

Rhinitis, Allergic, Perennial

United States
Teva Branded Pharmaceutical Products R&D, Inc.

Completed

Hypothalamic-Pituitary-Adrenal (HPA)-Axis Study in Pediatric Subjects With Perennial Allergic Rhinitis (PAR)

Allergic Rhinitis

United States
Allergy Therapeutics
Inflamax Research Incorporated; Metronomia Clinical Research GMBH

Completed

A Study of Tolerability and Safety of Two New Doses of Grass MATA MPL

Allergic Rhinitis

United States
New York City Health and Hospitals Corporation

Completed

The Effect of Cetirizine on Bronchoconstriction

Asthma | Allergic Rhinitis

United States
Sanofi

Completed

Study of Triamcinolone Acetonide on the Growth Velocity of Children, Ages 3 to 9, With Perennial Allergic Rhinitis (PAR)

Rhinitis, Allergic, Perennial

United States
Community and Patient Preference Research Pty Ltd
Seqirus Limited; Glenmark Pharmaceuticals

Withdrawn

Impact of RYALTRIS® Nasal Spray on Patients' Reported Outcomes

Allergic Rhinitis

Australia
Meda Pharmaceuticals

Completed

A Study to Evaluate the Safety and Effectiveness of a Nasal Spray to Treat Perennial Allergies

Perennial Allergic Rhinitis

United States
Meda Pharmaceuticals

Completed

A Study to Evaluate the Safety and Effectiveness of a Nasal Spray to Treat Seasonal Allergies

Seasonal Allergic Rhinitis

United States
Meda Pharmaceuticals

Completed

A Study to Evaluate the Safety & Effectiveness of a Nasal Spray to Treat Seasonal Allergies

Seasonal Allergic Rhinitis

United States

3

Subscribe